文献速递主动脉外科瓣膜外科

50岁以下患者保留瓣膜的主动脉根部置换与生物瓣复合带瓣管道置换的比较

Valve-sparing aortic root replacement versus composite valve graft with bioprosthesis in patients under age 50.
PubMed 文献 · J Thorac Cardiovasc Surg · 2023-07-21

本研究比较50岁以下患者行保留瓣膜的主动脉根部置换(VSRR)与生物瓣复合带瓣管道置换(b-CVG)的长期结局,纳入2004至2021年2个主动脉中心的543例患者。b-CVG与较低的12年生存率和较高的主动脉瓣再干预率相关,倾向性评分匹配后生存相似,但b-CVG在术后4年以上与主动脉瓣再干预独立相关。作者认为在符合条件的年轻患者中应尽力保留自体主动脉瓣。

要点

  • b-CVG组12年生存率低于VSRR组(88.6% vs 92.9%,P=.036)。
  • 倾向性评分匹配后两组生存相似(b-CVG组93.4% vs VSRR组93.0%,P=.72)。
  • b-CVG与术后4年以上主动脉瓣再干预独立相关(Fine and Gray亚分布风险比4.3,95%CI 1.8-10.2,P=.001)。

核心结论

  • 在年轻患者中,b-CVG与早期瓣膜退变相关,甚至10年内再手术主动脉瓣置换率增加;相比之下,VSRR耐久且生存极佳;在符合条件的年轻患者中,应尽力保留自体主动脉瓣。

研究设计与样本

  • 回顾性比较研究,纳入2004至2021年2个主动脉中心的543例年龄<50岁患者,其中VSRR组335例,b-CVG组208例,排除主动脉夹层或心内膜炎患者。

主要发现

  • 与VSRR相比,b-CVG与较低的12年生存率相关(88.6% vs 92.9%;P=.036)和较高的主动脉瓣再干预率相关(37.6% vs 12.0%;P=.018)。
  • 倾向性评分匹配后,两组生存相似(b-CVG组93.4% vs VSRR组93.0%;P=.72)。
  • Fine and Gray多变量风险回归和倾向性评分匹配均显示b-CVG与术后4年以上主动脉瓣再干预独立相关(Fine and Gray:亚分布风险比4.3,95%CI 1.8-10.2,P=.001;倾向性评分匹配:b-CVG组35.7% vs VSRR组14.3%;P=.024)。
  • 倾向性评分匹配后10年大于中度主动脉瓣反流/狭窄率在b-CVG组是VSRR组的2倍以上(37.1% vs 15.9%;P=.571)。

临床怎么用

  • 作者认为,在符合条件的年轻患者中,应尽力保留自体主动脉瓣。

局限性

  • 原文未报告局限性

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Although the unique risks of implanting a prosthetic valve after aortic valve (AV) surgery in young patients are well established, studies of aortic root replacement (ARR) are lacking. We investigated long-term outcomes after valve-sparing root replacement (VSRR) versus the use of a composite valve graft with bioprosthesis (b-CVG) in patients age <50 years. METHODS: A total of 543 patients age <50 years underwent VSRR (n = 335) or b-CVG (n = 208) between 2004 and 2021 from 2 aortic centers, excluding those with dissection or endocarditis. Endpoints included mortality over time, reoperative aortic valve replacement (AVR), and development of greater than moderate aortic insufficiency (AI) or aortic stenosis (AS). Fine and Gray competing risk regression was used to compare the risk of reintervention. Propensity score matching (PSM) balanced patient comorbidities, and landmark analysis isolated outcomes beginning 4 years postoperatively. RESULTS: Compared with VSRR, b-CVG was associated with lower 12-year survival (88.6% vs 92.9%; P = .036) and a higher rate of AV reintervention (37.6% vs 12.0%; P = .018). After PSM, survival was similar in the 2 arms (93.4% for b-CVG vs 93.0% for VSRR; P = .72). However, both Fine and Gray multivariable risk regression and PSM showed that b-CVG was independently associated with AV reintervention at >4 years postoperatively (Fine and Gray: subdistribution hazard ratio, 4.3 [95% confidence interval, 1.8-10.2; P = .001]; PSM: 35.7% for b-CVG versus 14.3% for VSRR; P = .024]). PSM rates of greater than moderate AI/AS at 10 years were more than 2-fold greater in the b-CVG arm compared with the VSRR arm (37.1% vs 15.9%; P = .571). CONCLUSIONS: b-CVG in young patients is associated with early valvular degeneration, with increasing rates of reoperative AVR occurring even within 10 years. In contrast, VSRR is durable with excellent survival. In eligible young patients, every effort should be made to retain the native AV.

来源:J Thorac Cardiovasc Surg,查看原文。版权归原作者所有。

引用

  1. Levine D, Patel P, Zhao Y, et al. Valve-sparing aortic root replacement versus composite valve graft with bioprosthesis in patients under age 50. J Thorac Cardiovasc Surg. 2023. PMID: 37480983. doi:10.1016/j.jtcvs.2023.07.016

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。